These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 34578363)

  • 1. Clinical Characterization and Genomic Analysis of Samples from COVID-19 Breakthrough Infections during the Second Wave among the Various States of India.
    Gupta N; Kaur H; Yadav PD; Mukhopadhyay L; Sahay RR; Kumar A; Nyayanit DA; Shete AM; Patil S; Majumdar T; Rana S; Gupta S; Narayan J; Vijay N; Barde P; Nataraj G; B AK; Kumari MP; Biswas D; Iravane J; Raut S; Dutta S; Devi S; Barua P; Gupta P; Borkakoty B; Kalita D; Dhingra K; Fomda B; Joshi Y; Goyal K; John R; Munivenkatappa A; Dhodapkar R; Pandit P; Devi S; Dudhmal M; Kinariwala D; Khandelwal N; Tiwari YK; Khatri PK; Gupta A; Khatri H; Malhotra B; Nagasundaram M; Dar L; Sheikh N; Shastri J; Aggarwal N; Abraham P
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Epidemiology of AY.28 and AY.104 Delta Sub-lineages in Sri Lanka.
    Ranasinghe D; Jayathilaka D; Jeewandara C; Gunasinghe D; Ariyaratne D; Jayadas TTP; Kuruppu H; Wijesinghe A; Bary FF; Madhusanka D; Pushpakumara PD; Guruge D; Wijayamuni R; Ogg GS; Malavige GN
    Front Public Health; 2022; 10():873633. PubMed ID: 35801250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic Analysis of AZD1222 (ChAdOx1) Vaccine Breakthrough Infections in the City of Mumbai.
    Shetty A; Chatterjee G; Rajpal S; Srivastava T; Gardi N; Mirgh S; Gokarn A; Punatar S; Shetty N; Joshi A; Nair S; Murthy V; Khattry N; Tembhare P; Dikshit R; Chaturvedi P; More A; Kamtalwar S; Chavan P; Bhat V; Patil A; Dhumal S; Bhat P; Subramanian P; Gujral S; Badwe R; Patkar N; Gupta S
    Int J Clin Pract; 2022; 2022():2449068. PubMed ID: 35685574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular epidemiology of SARS-CoV-2 in healthcare workers and identification of viral genomic correlates of transmissibility and vaccine break through infection: A retrospective observational study from a cancer hospital in eastern India.
    Bhattacharya S; Chatterji S; Chandy M; Mahajan AY; Goel G; Mishra D; Vivek P; Das P; Mandal S; Chugani A; Mittal A; Perumal RC; Ramprasad VL; Gupta R
    Indian J Med Microbiol; 2023; 41():104-110. PubMed ID: 36244851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic characterization unravelling the causative role of SARS-CoV-2 Delta variant of lineage B.1.617.2 in 2nd wave of COVID-19 pandemic in Chhattisgarh, India.
    Singh P; Sharma K; Singh P; Bhargava A; Negi SS; Sharma P; Bhise M; Tripathi MK; Jindal A; Nagarkar NM
    Microb Pathog; 2022 Mar; 164():105404. PubMed ID: 35065253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variants of concern responsible for SARS-CoV-2 vaccine breakthrough infections from India.
    Singh UB; Rophina M; Chaudhry R; Senthivel V; Bala K; Bhoyar RC; Jolly B; Jamshed N; Imran M; Gupta R; Aggarwal P; Divakar MK; Sinha S; Arvinden VR; Bajaj A; Shamnath A; Jain A; ; Scaria V; Sivasubbu S; Guleria R
    J Med Virol; 2022 Apr; 94(4):1696-1700. PubMed ID: 34786733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomics of postvaccination SARS-CoV-2 infections during the Delta dominated second wave of COVID-19 pandemic, from Mumbai Metropolitan Region (MMR), India.
    Nilgiriwala K; Kadam P; Patel G; Shaikh A; Mestry T; Vaswani S; Sakthivel S; Poojary A; Gandhi B; Rohra S; Udwadia Z; Oswal V; Shah D; Gomare M; Sriraman K; Mistry N
    J Med Virol; 2022 Sep; 94(9):4206-4215. PubMed ID: 35578378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic diversity of SARS-CoV-2 in Pakistan during the fourth wave of pandemic.
    Umair M; Ikram A; Rehman Z; Haider SA; Ammar M; Badar N; Ali Q; Rana MS; Salman M
    J Med Virol; 2022 Oct; 94(10):4869-4877. PubMed ID: 35754094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative frequency of genomic mutations in SARS-CoV-2 recovered from southern Brazilian cases of COVID-19 through the Gamma, Delta and Omicron waves.
    Filippi M; Demoliner M; Gularte JS; de Abreu Goes Pereira VM; da Silva MS; Girardi V; Hansen AW; Spilki FR
    Infect Genet Evol; 2024 Jun; 120():105590. PubMed ID: 38574833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and genomic signatures of SARS-CoV-2 Delta breakthrough infections in New York.
    Duerr R; Dimartino D; Marier C; Zappile P; Levine S; Francois F; Iturrate E; Wang G; Dittmann M; Lighter J; Elbel B; Troxel AB; Goldfeld KS; Heguy A
    EBioMedicine; 2022 Aug; 82():104141. PubMed ID: 35906172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 variants and spike mutations involved in second wave of COVID-19 pandemic in India.
    Muttineni R; R N B; Putty K; Marapakala K; K P S; Panyam J; Vemula A; Singh SM; Balachandran S; S T VR; Kondapi AK
    Transbound Emerg Dis; 2022 Sep; 69(5):e1721-e1733. PubMed ID: 35266305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative Consolidation of the Kappa Variant Pre-Dates the Massive Second Wave of COVID-19 in India.
    Singh J; Malhotra AG; Biswas D; Shankar P; Lokhande L; Yadav AK; Raghuvanshi A; Kale D; Nema S; Saigal S; Singh S
    Genes (Basel); 2021 Nov; 12(11):. PubMed ID: 34828410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breakthrough infection with SARS-CoV-2 delta variant in old-age homes in a Southern District of Kerala, India.
    Chandran D; Sreekumar E; Prajitha KC; Sharahudeen A; Raveendran CL;
    Indian J Public Health; 2022 Nov; 66(Supplement):S36-S40. PubMed ID: 36412471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination.
    Yang W; Shaman J
    medRxiv; 2021 Nov; ():. PubMed ID: 34845460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 AY.4.2 variant circulating in Italy: Genomic preliminary insight.
    Angeletti S; Giovanetti M; Fogolari M; Cella E; De Florio L; Lintas C; Veralli R; Francesconi M; Caccuri F; De Cesaris M; De Flora C; Ceccarelli G; Spoto S; Caruso A; Pascarella S; Riva E; Ciccozzi M
    J Med Virol; 2022 Apr; 94(4):1689-1692. PubMed ID: 34766651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Delta variant wave in Tunisia: Genetic diversity, spatio-temporal distribution and evidence of the spread of a divergent AY.122 sub-lineage.
    Haddad-Boubaker S; Arbi M; Souiai O; Chouikha A; Fares W; Edington K; Sims S; Camma C; Lorusso A; Diagne MM; Diallo A; Boubaker IBB; Ferjani S; Mastouri M; Mhalla S; Karray H; Gargouri S; Bahri O; Trabelsi A; Kallala O; Hannachi N; Chaabouni Y; Smaoui H; Meftah K; Bouhalila SB; Foughali S; Zribi M; Lamari A; Touzi H; Safer M; Alaya NB; Kahla AB; Gdoura M; Triki H
    Front Public Health; 2022; 10():990832. PubMed ID: 36684874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 lineage dynamics in England from September to November 2021: high diversity of Delta sub-lineages and increased transmissibility of AY.4.2.
    Eales O; Page AJ; de Oliveira Martins L; Wang H; Bodinier B; Haw D; Jonnerby J; Atchison C; ; Ashby D; Barclay W; Taylor G; Cooke G; Ward H; Darzi A; Riley S; Chadeau-Hyam M; Donnelly CA; Elliott P
    BMC Infect Dis; 2022 Jul; 22(1):647. PubMed ID: 35896970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic surveillance of SARS-CoV-2 and emergence of XBB.1.16 variant in Rajasthan.
    Sharma P; Gautam S; Sharma A; Parsoya D; Deeba F; Pal N; Singh R; Sharma H; Bhomia N; Sharma RP; Potdar V; Malhotra B
    Indian J Med Microbiol; 2024; 50():100659. PubMed ID: 38945273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic Surveillance of SARS-CoV-2 Lineages Indicates Early Circulation of P.1 (Gamma) Variant of Concern in Southern Brazil.
    Wink PL; Ramalho R; Monteiro FL; Volpato FCZ; Willig JB; Lovison OVA; Zavascki AP; Barth AL; Martins AF
    Microbiol Spectr; 2022 Feb; 10(1):e0151121. PubMed ID: 35171035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic characterization of the dominating Beta, V2 variant carrying vaccinated (Oxford-AstraZeneca) and nonvaccinated COVID-19 patient samples in Bangladesh: A metagenomics and whole-genome approach.
    Rahaman MM; Sarkar MMH; Rahman MS; Islam MR; Islam I; Saha O; Akter S; Banu TA; Jahan I; Habib MA; Goswami B; Bari L; Malek MA; Khan MS
    J Med Virol; 2022 Apr; 94(4):1670-1688. PubMed ID: 34939673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.